Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 01, 2015 9:39 PM ET


Company Overview of Excelimmune, Inc.

Company Overview

Excelimmune, Inc., a biopharmaceutical company, engages in the development of human recombinant polyclonal antibodies for therapeutic use. The company focuses on the treatment of infections caused by staphylococcus aureus, including the drug resistant superbug, methicillin-resistant staphylococcus aureus. It offers a platform for developing human recombinant polyclonal antibody therapeutics for therapeutic applications, such as the treatment of infectious diseases, protein diseases, and cancer. Excelimmune, Inc. was founded in 2006 and is based in Woburn, Massachusetts.

12-B Cabot Road

Woburn, MA 01801

United States

Founded in 2006





Key Executives for Excelimmune, Inc.

Chief Executive Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2015.

Excelimmune, Inc. Key Developments

Catalent and Excelimmune Inc Sign Licensing Agreement for ACT Tech Platform

Catalent Inc. announced that it had entered into an exclusive licensing agreement giving it access to the antibody combination therapy (ACT) technology platform developed by Excelimmune Inc. The terms of the deal, whose financial value was not disclosed, envision Catalent continuing development work on the platform, both internally and through partner-sponsored programmes. Catalent can advance that development by leveraging its own GPEx technology.

Similar Private Companies By Industry

Company Name Region
Glycoregimmune, Inc. United States
Center for Biocatalysis and Bioprocessing United States
Applied Catheter Technologies, Inc. United States
Tolerance Therapeutics LLC United States
Genevac, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Excelimmune, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at